Anthony Krick Net Worth

The estimated Net Worth of Anthony J Krick is at least 142 千$ dollars as of 17 July 2024. Mr Krick owns over 6,845 units of OptiNose Inc stock worth over 129,497$ and over the last 2 years he sold OPTN stock worth over 12,954$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Krick OPTN stock SEC Form 4 insiders trading

Mr has made over 3 trades of the OptiNose Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 6,845 units of OPTN stock worth 7,803$ on 17 July 2024.

The largest trade he's ever made was selling 6,845 units of OptiNose Inc stock on 17 July 2024 worth over 7,803$. On average, Mr trades about 1,963 units every 24 days since 2023. As of 17 July 2024 he still owns at least 140,758 units of OptiNose Inc stock.

You can see the complete history of Mr Krick stock trades at the bottom of the page.

Mr. Anthony Krick biography

Anthony Krick is the VP & Chief Accounting Officer at OptiNose Inc.

What's Mr Krick's mailing address?

Anthony's mailing address filed with the SEC is C/O OPTINOSE, INC., 777 TOWNSHIP LINE ROAD, SUITE 300, YARDLEY, PA, 19067.

Insiders trading at OptiNose Inc

Over the last 19 years, insiders at OptiNose Inc have traded over 144,654,703$ worth of OptiNose Inc stock and bought 116,688 units worth 814,936$ . The most active insiders traders include Sriram Venkataraman、Capital Partners Ii Gp, Llc...、Rajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of 106,645$. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth 7,803$.

What does OptiNose Inc do?

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo

Complete history of Mr Krick stock trades at OptiNose Inc

OptiNose Inc executives and stock owners

OptiNose Inc executives and other stock owners filed with the SEC include:

• Peter Miller,
  Chief Executive Officer, Director
• Ramy Mahmoud,
  President, Chief Operating Officer
• Michael Marino,
  Chief Legal Officer and Corporate Secretary
• Peter K. Miller,
  CEO & Director
• Keith Goldan,
  Chief Financial Officer
• Dr. Ramy A. Mahmoud M.D., M.P.H.,
  Pres & COO
• Michael F. Marino,
  Chief Legal Officer & Corp. Sec.
• Keith Alan Goldan,
  Chief Financial Officer
• Victor M. Clavelli,
  Chief Commercial Officer
• Michael F. Marino Esq.,
  Chief Legal Officer & Corp. Sec.
• Joseph Scodari,
  Independent Chairman of the Board
• Sandra Helton,
  Independent Director
• Wilhelmus Groenhuysen,
  Independent Director
• William Doyle,
  Independent Director
• Jonathan Neely,
  VP Investor Relations and Business Operations
• Catherine Owen,
  Director
• Victor Clavelli,
  Chief Commercial Officer
• Anthony Krick,
  VP & Chief Accounting Officer
• Michele Janis MBA,
  VP & Acting CFO
• Dr. Per Gisle Djupesland M.D., Ph.D.,
  Co-Founder & Chief Scientific Officer of OptiNose AS
• Helena Kyttari Djupesland,
  Co-Founder of Optinose AS (Norway) & Co-CEO of Optinose AS (Norway)
• John Messina,
  Sr. VP of Clinical Devel. & Medical Affairs
• Karen E. Brophy,
  VP of HR
• Paul Mastrapa,
  CFO
• John N Kapoor,
  Director
• Edward A Blechschmidt,
  Director
• Leo Henikoff,
  Director
• Kenneth Abramowitz,
  Director
• Jerome Sheldon,
  Director
• Rajat Rai,
  CEO
• Joseph Bonaccorsi,
  Secretary
• Richard M Smith,
  President & COO
• Capital Partners Ii Gp, Llc...,
  
• Ventures Llctkwd Ventures L...,
  
• Fund Lp Entrepreneurs Fund ...,
  
• Rick Bierly,
  Director
• Sriram Venkataraman,
  Director
• Larry G Pickering,
  Director
• Thomas Edward Gibbs,
  Chief Commercial Officer
• Joshua Alexander Tamaroff,
  Director
• Robert P O'neil,
  Director
• Ventures Llc Wfd,
  10% owner
• Ventures Llc Tkwd,
  10% owner
• Anthony J Krick,
  Chief Accounting Officer
• Tomas J. Heyman,
  Director
• Kyle Dempsey,
  Director
• Eric Bednarski,
  Director
• R John Fletcher,
  Director
• Paul Jr. Spence,
  Chief Commercial Officer
• Michele Janis,
  Acting Chief Financial Officer